Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-062008
Filing Date
2022-12-19
Accepted
2022-12-19 17:57:25
Documents
1
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3362
  Complete submission text file 0001209191-22-062008.txt   4806
Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Issuer) CIK: 0001814140 (see all company filings)

EIN.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APEXIGEN, INC. 75 SHOREWAY ROAD SAN CARLOS CA 94070
Business Address
Wong Amy (Reporting) CIK: 0001940217 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39488 | Film No.: 221472301